Cargando…
Cue restricted smoking increases quit rates with varenicline
INTRODUCTION: Varenicline effectively helps smokers quit by reducing withdrawal symptoms and blocking the reward of smoking. However, most quitters return to smoking within one year. ‘Cue Restricted Smoking’ is a behavioral technique designed to increase quit rates by asking smokers attempting to qu...
Autores principales: | Scholz, Jaqueline R., Abe, Tania O., Gaya, Patricia V., Bellini, Bianca, de Moraes, Iana R. A., Santos, Juliana R., Tomaz, Paulo R. X., de Lima Santos, Paulo C., Tonstad, Serena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Publishing on behalf of the European Network for Smoking and Tobacco Prevention (ENSP)
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114580/ https://www.ncbi.nlm.nih.gov/pubmed/34017927 http://dx.doi.org/10.18332/tpc/133570 |
Ejemplares similares
-
Profile of the Nicotinic Cholinergic Receptor Alpha 7 Subunit Gene Expression is Associated with Response to Varenicline Treatment
por: Santos, Juliana Rocha, et al.
Publicado: (2020) -
CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy
por: Rocha Santos, Juliana, et al.
Publicado: (2015) -
Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion
por: Tomaz, Paulo Roberto Xavier, et al.
Publicado: (2022) -
Varenicline in smokers with diabetes: A pooled analysis of 15 randomized, placebo‐controlled studies of varenicline
por: Tonstad, Serena, et al.
Publicado: (2016) -
Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women
por: Tomaz, Paulo Roberto Xavier, et al.
Publicado: (2018)